White label ELPA - ClinicalTrials.eu

Study on Anastrozole, Letrozole, Exemestane, and Tamoxifen for Women Aged 70+ with Early Stage Breast Cancer

Not recruiting

3 1 1 1
Investigated Drugs:
Study on the Safety and Use of AVT06 (Aflibercept) for Patients with Chorioretinal Vascular Diseases

Not recruiting

3 1 1
Investigated Diseases:
Investigated Drugs:
- Aflibercept
Study on the Safety and Effectiveness of ABC008 for Patients with Inclusion Body Myositis

Not recruiting

4 1
Investigated Diseases:
- Inclusion body myositis
Investigated Drugs:
- ULVIPRUBART
Study on Managing Moderate Postoperative Recurrence in Crohn’s Disease with Infliximab for Patients After Ileocolonic Surgery

Not recruiting

3 1 1 1
Investigated Diseases:
- Crohn’s disease
Investigated Drugs:
- Infliximab
Study on Montelukast for Pain Relief in Patients with Erosive Hand Osteoarthritis

Not recruiting

2 1
Investigated Diseases:
- Osteoarthritis
Investigated Drugs:
- Montelukast
Study on the Effectiveness and Safety of Tanimilast for Patients with Uncontrolled Asthma on Inhaled Corticosteroid and Long-Acting Beta2-Agonist Therapy

Not recruiting

2 1
Investigated Diseases:
- Asthma
Investigated Drugs:
- Tanimilast
+4
Study of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema

Not recruiting

3 1
Investigated Diseases:
- Dermatitis atopic
Investigated Drugs:
- Upadacitinib
+9
Study of Pembrolizumab and Chemotherapy for Patients with HR+/HER2- Advanced Breast Cancer

Not recruiting

3 1 1
Investigated Diseases:
- Breast cancer
Investigated Drugs:
+7
Study on Methotrexate, Tafasitamab, Lenalidomide, and Rituximab for Patients with Primary Central Nervous System Lymphoma Not Eligible for Stem Cell Transplant

Not recruiting

2 1 1 1
Investigated Diseases:
- Central nervous system lymphoma
Investigated Drugs:
Study on the Accuracy of OWL-EVO1 Test for Diagnosing Lung Cancer in Patients Eligible for Screening or with Suspicious CT Findings

Not recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- D5-Ethyl-Beta-D-Glucuronide

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies